Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2012

Dec 18, 2012

34978_dirs_2012-12-17_a65c4274-ab62-496d-8548-598309e24bbe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2012-12-13

Reporting Person: Mackaness James H (CFO and COO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-13 Stock Option Right to Buy $3.856 A 72500 Acquired 2019-12-13 Common Stock (72500) Direct

Footnotes

F1: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.

F2: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.